GB2584647A - Skin treatment composition - Google Patents

Skin treatment composition Download PDF

Info

Publication number
GB2584647A
GB2584647A GB1908076.1A GB201908076A GB2584647A GB 2584647 A GB2584647 A GB 2584647A GB 201908076 A GB201908076 A GB 201908076A GB 2584647 A GB2584647 A GB 2584647A
Authority
GB
United Kingdom
Prior art keywords
composition
skin
composition according
emollient
humectant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB1908076.1A
Other versions
GB201908076D0 (en
Inventor
Hussein Sudef
Darroch Colin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston Healthcare Ltd
Original Assignee
Boston Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston Healthcare Ltd filed Critical Boston Healthcare Ltd
Priority to GB1908076.1A priority Critical patent/GB2584647A/en
Publication of GB201908076D0 publication Critical patent/GB201908076D0/en
Priority to PCT/GB2020/051324 priority patent/WO2020245569A1/en
Publication of GB2584647A publication Critical patent/GB2584647A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • A61K8/922Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/007Preparations for dry skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/28Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/30Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/77Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/886Aloeaceae (Aloe family), e.g. aloe vera
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216Solid or semisolid forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216Solid or semisolid forms
    • A61K8/0229Sticks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04Dispersions; Emulsions
    • A61K8/042Gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67Vitamins
    • A61K8/678Tocopherol, i.e. vitamin E
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/92Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/30Characterized by the absence of a particular group of ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)

Abstract

A composition comprising a skin-conditioning agent, an emollient, a humectant, and no more than 2.0 % of any paraffin-based component, is provided. Preferably the composition is substantially or completely free of any paraffin-based component. The composition may be used to treat dry skin conditions, such as psoriasis, eczema, and dermatitis. The composition may be in the form of a spray, cream, lotion, balm, gel, serum, oil, or solid stick. The composition may comprise 0.5-10 % (preferably 2-8 %) skin conditioning agent, 2-25 % (preferably 5-20 %) emollient, and 1-10 % (preferably 1.5-8 %) humectant. The composition may comprise additional excipients, such as a chelating agent, preservative, a stabiliser or thickener, an emulsion stabiliser or thickener, a non-ionic emulsifier, and a pH adjuster. The emollient may be isostearyl isostearate, caprylic or capric triglyceride, decyl oleate, C12-15 alkyl benzoate, myristyl myristate, coco-caprylate or coco-caprate or any natural oil or butter. The humectant may be glycerine, sodium pyrrolidone carbonic acid, sodium hyaluronate, propanediol, zinc pyrrolidone carbonic acid, betaine, panthenol, or natural plant extracts. The skin-conditioner may be octyldodecanol, Echium plantagineum seed oil, Helianthus annus seed oil unsaponifables, extract of Cardiospermum halicacabum, 5-ureidohydantoin, levomenol, biotin, an Aloe vera-containing component, and/or an oat-containing component.

Description

Skin Treatment Composition The present invention relates to a composition which can be used in the treatment of the skin, including skin conditions such as psoriasis, eczema, dermatitis, and other dry skin conditions, wherein the composition is substantially free of any paraffin-based components.
Compositions for use in the treatment of skin conditions have been known for some time. Examples of known commercially available products include those marketed as Cetreben Cream, Hydromol Cream and Ultrabase cream. These products are all supplied in tubs and pumps in a cream format, and are known to contain large quantities of paraffin-based ingredients such as Paraffinum Liquidum (Mineral Oil) and Petrolatum, which results in very rich and very heavy creams. These products work by offering a skin-barrier effect.
However, paraffin-based products, and even products which contain paraffin-based emollients, have recently come under fire due to the dangers of dressing, clothing and bedclothes which is used to cover emollient products. Such dressing, clothing and bedclothes is brought into contact with the products, absorbs them, and can then potentially catch fire if exposed to a naked flame. There are recorded incidents of this occurring. This is clearly an eventuality which is not desirable. The products are also a fire hazard upon packing.
It would therefore be desirable to develop a composition which can be used in the treatment of skin conditions such as psoriasis, eczema, dermatitis, and other dry skin conditions, which contains very little, or does not contain any paraffin-based components, and which can therefore be used safely, without the potential risk of combustion.
Therefore, in accordance with the invention, there is provided a composition comprising a skin-conditioning agent, an emollient, and a humectant, wherein the composition comprises no more than about 2.0 wt% of any paraffin-based components According to one embodiment of the invention, the composition comprises no more than about 1.0 wt%, or 0.5 wt%, of any paraffin-based components.
According to another embodiment of the invention, the composition is substantially free or completely free of any paraffin-based components.
The skin-conditioning agent is an ingredient which enhances the appearance of dry or damaged skin by reducing flaking and restoring suppleness, regenerating the skin barrier, or which attracts and holds moisture in the skin. It may also slow the loss of water from the skin by forming a barrier on the skin's surface, and act as a lubricant on the skin surface, which gives the skin a soft and smooth appearance.
The skin-conditioning agent may comprise octyldodecanol, Hel anthus Annuus (sunflower) seed oil unsaponifiables (including phytosterole, tocopherole and squale), and Cardiospermum Halicacabum flower/leaf/vine extract. It may also contain echium plantagineum seed oil (2H-1-Benzopyran-6-ol, 3,4-dihydro-2,7,8-trimethy1-2-(4,8,12-trimethyltridecy1)42R42R*(4R*,8R*)]] ).
One such skin-conditioning agent which may be used in accordance with the invention is marketed under the trade name Defensila Defensil is a skin-conditioning agent that is used as primarily as a cosmetic agent, for example in the prevention of skin blemishes and control pimple-causing bacteria against pimples and spots, and is a blend of different 'cosmetic active' ingredients, which include octyldodecanol, echium plantagineum seed oil (2H-1-Benzopyran-6-ol, 3,4-dihydro-2,7,8-trimethy1-2- (4,8,1 2-trim ethyltri decy1)42 R-[2 R*(4R*,8 R *)]] ), H el i anthus Annuus (sunflower) seed oil unsaponifiables (including phytosterole, tocopherole and squale), and Cardiospermum Hal cacabum flower/leaf/vine extract. The ech um oil is very rich in stearidonic acid (an omega 3 fatty acid), has anti-inflammatory properties, and protects and strengthens the skin barrier; the unsaponifiable elements of the sunflower oil provide valuable nutritional elements such as phytosterols and squalene; and the Cardiospermum Halicacabum is effective against itching and allergenic skin rashes. A 2% Defensil composition has been shown in studies to be as effective on skin irritations over 2 hours as a 0.5% hydrocortisone composition.
Alternative skin-conditioning agents which may be used in the composition of the invention include, but are not limited to, one or more of the following: - Allantoin -which is a diureide of glyoxylic acid with the chemical formula C41-16151403, and is also called 5-ureidohydantoin or glyoxyldiureide, -Bisabalol -or more formally u-(-)-bisabolol, and is also known as levomenol, which is a natural monocyclic sesquiterpene alcohol; - Aloe vera-containing ingredients; - Biotin -also known as vitamin H, and is one of the B complex vitamins, - One of more silicones, such as dimethicone; -One or more amino acids, such as arginine; - One or more proteins, such as hydrolysed wheat protein; - One or more peptides, such as hexapeptide-t * and/or An oat-containing component, which are known to have skin soothing properties These may include, for example, oat extracts, oat milk, oat proteins or oat oil.
Any of the skin-conditioning agents mentioned herein may be used alone or in combination in the composition of the invention.
As mentioned, the composition of the invention has been developed without the use of any paraffin-based emollients. In one embodiment, the composition of the invention is completely free of any paraffin-based components.
Instead, it has been developed with an alternative light emollient. An emollient is a preparation that softens the skin, by helping to keep the skin moist and supple by reducing water loss from the epidermis, the outer layer of skin. In the language of cosmetics or dermo-cosmetics, an emollient is a re-fatting agent, i.e. an ingredient of a cosmetic formulation that provides the skin with the fat it needs. It reduces evaporation and thus increases the moisture content of the skin.
Non-limiting examples of such emollients include one or more selected from isostearyl isostearate, caprylic or capric triglyceride, decyl oleate, Cu-Ci5 alkyl benzoate, myristyl myristate, coco-caprylate or coco-caprate, or any natural oil or butter (such as, but not limited to, almond oil, shea butter, or olive oil). Typically, the composition comprises an amount of isostearyl isostearate Isostearyl isostearate offers skin moisture barrier enhancing effects and improved spreadability on the skin. It offers a velvety skin feel is easily absorbed into the skin, leaving a non-greasy after-feel.
S
There may be components within the skin-conditioning agent which would also offer some skin emolliency benefits. For example, octydodcecanol and echium plantagineum seed oil are able to do this The composition of the invention also contains a humectant, which will help retain moisture in the skin. The humectant is a different, additional, component to the emollient. Non-limiting examples of humectants which may be used in the composition of the invention include, but are not limited to, one or more selected from glycerine, sodium pyrrolidone carbonic acid (sodium PCA), sodium hyaluronate, propanediol, zinc pyrrolidone carbonic acid (zinc PCA), betaine, panthenol, or natural plant extracts (such as, for example, Opuntia Ficus-Indica Stem Extract which is a cactus extract offering skin hydrating properties; and Citrus Limon (Lemon) Fruit Water which also offers also offers nourishing and hydrating properties).
The composition of the invention may also contain one or more further additive components. Such additive components may include, for example, one or more of a chelating agent (such as disodium EDTA), a preservative (such as potassium sorbate and/or phenoxyethanol and/or ethylhexylglycerin), a stabiliser or thickener (such as xanthan gum), an emulsion stabiliser or thickener (such as cetearyl alcohol), a non-ionic emulsifier (such as glyceryl stearate and/or polyethylene glycol-100 stearate, and/or ceteareth-20), a component to enhance emulsifying/stabilising/thickening properties further (such as sodium polyacryl ate and water), and a pH adjuster (such as citric acid). The pH of the composition is typically between about 5.0 and 6.0, such as about 5.5. In total, these additives typically do not constitute more than about 10 wt% of the composition.
The composition is also typically made up to 100 wt% with water.
According to one embodiment of the invention, the composition may contain from about 0.5 to about 10 wt% of the skin-conditioning agent; more typically from about 2 to about 8 wt%; more typically from about 3 to about 7 wt%i more typically from about 4 to about 6 wt%.
According to one embodiment of the invention, the composition may contain from about Ito about 30 wt% of the emollient; more typically from about 2 to about 25 wt%; more typically from about 5 to about 20 wt% more typically from about 7.5 to about 15 wt%, or from about 8 to about 12 wt%. If more than about 10 wt% of the humectant is used, the composition may become rather tacky and have an unpleasant feel on the skin.
According to one embodiment of the invention, the composition may contain from about 1 to about 10 wt% of the humectant; more typically from about 1.5 to about 8 wt%; more typically from about 2 to about 5 wt%.
The composition of the invention may be provided in any suitable form for application to the skin of a person, such as but not limited to, in the form of a spray, a cream, a lotion, a balm, a gel, a serum, an oil, or a solid stick. The particular thickeners and emulsifiers, and their amounts in the composition, can be adjusted as necessary in order to provide the composition in whichever form is desired. When the composition is in a sprayable format, this also helps with the product dosage, light skin-feel and quick-drying effect on the skin.
The composition of the invention constitutes an improvement on the standard emollients on the market, and can be distinguished because it uses a combination of a non-paraffin based emollient, a humectant and a known ingredient with skin soothing and anti-inflammatory benefits, offering greater skin protection compared to products already on the market which work by only offering an emollient effect.
The composition of the invention as defined here nabove, comprising a skin-conditioning agent, an emollient, and a humectant, wherein the composition is substantially free of any paraffin-based components is provided for the treatment of dry skin conditions, such as but not limited to, psoriasis, eczema, and dermatitis The present invention also provides a method of manufacturing a composition comprising a skin-conditioning agent, an emollient, and a humectant, wherein the composition is substantially free of any paraffin-based components, the method comprising the steps of combining a skin-conditioning agent, an emollient, and a humectant, wherein the composition comprises no more than about 2.0 wt% of any paraffin-based components.
According to one embodiment, the humectant is a different, additional, component to the emollient.
According to another embodiment, the humectant and emollient, which are typically different materials, are combined together before addition of the skin-conditioning agent.
In an exemplary, but non-limiting, method of the invention: Phase A: additive components -such as a chelating agent and/or a preservative -is heated in water up to a temperature of about 70-80°C. The humectant is mixed with a stabiliser or thickener (such as xanthan gum), and this mixture (PM1) is added to the mixture containing the water and additive components, with stirring and homogenising, until the stabiliser or thickener has completely dispersed.
Phase B: In a separate vessel, the emollient is heated up to a temperature of about 70-80°C with an emulsion stabiliser/thickener, one or more non-ionic emulsifiers, and an emulsifying polymer. Once the mixtures from Phase A and Phase B are at temperature, they are combined together. The new mixture is then cooled to about 35-45°C.
At this temperature, the skin-conditioning agent and a cosmetic preservative are added, with gentle homogenising. The pH of the mixture is then tested, and adjusted if required with a cosmetically-approved pH adjuster such as citric acid.
According to a further aspect of the invention, there is provided a use of a composition comprising a skin-conditioning agent, an emollient, and a humectant, wherein the composition is substantially free of any paraffin-based components, for the treatment of dry skin conditions, such as but not limited to, psoriasis, eczema, and dermatitis.
The invention will now be described further by way of example with reference to the following examples which are intended to be illustrative only and in no way limiting upon the scope of the invention.
EXAMPLES Method
Lab Formula/Quantity/Weight Materitd Code RN/1001894 RI\4003044 RM000091 Phase A Material Name Demineralised Water Disodium Edetate Potassium Sorbate (B202) Glycerine VEG PG/PH Kosher % Material 74.298000 0.100000 0.400000 Quantity Unit RN1003295 A 3.000000 74.298000 A 0 100000 PM1 0.400000 3.000000 RI\4000733 PM1 Keltrol CG T 0.170000 0.170000 g RI\4002430 Isostearyl Isostearate 10.000000 10.000000 RM000023 Caflon CSA 0.150000 0.150000 RM000095 Lexemul 561 3.500000 3.500000 g RM000195 Eumulgin B2 2.000000 2.000000 g RM000332 Cosmedia SP 0.350000 0.350000 g RM000599 Euxyl PE 9010 1.000000 1.000000 g RM002109 Defensil 5.000000 5.000000 RM003218 Citric Acid EP 0.032000 0.032000g 100.000000 100.000000 g Operating instructions Keltrol CG T = Xanthan gum product Cation CSA = an emulsion stabiliser or thickener, specifically a cetearyl alcohol-based stabiliser/opacifying agent Lexemul 561 = a nonionic emulsifier, specifically a modified self-emulsifying Operating nstructiu 1. Add Water and remaining ingredients from phase A and heat to 75°C 2. Premix PM1 and add to the batch with stirring/homogenising. Ensure the Keltrol has completely dispersed.
3. In a separate beaker heat up phase B to 75°C.
4. Once both phases are at temperature, add B to A with homogenisation. Homogenise until uniform 5. Commence cooling the batch to 40°C 6 At 40°C add stage C ingredients with gentle homogenising. 7. Test and adjust the pH with citric acid in phase D. glyceryl monostearate Eumulgin B2 = a non-ionic emulsifier Cosmed a SP = Emulsifying polymer Euxyl PE 9010 = a liquid cosmetic preservative This formulation exhibits stability over a period of 3 months, without any separation of the components, as well as being completely free of any undesirable and unsafe paraffin-containing components It can therefore be seen that the compositions according to the invention provide an improved degree of skin conditioning to a person, and without the undesirable presence of a paraffin-based component present therein.
It is of course to be understood that the present Invention is not intended to be restricted to the foregoing examples which are described by way of example only.

Claims (19)

  1. CLAIMS1. A composition comprising a skin-conditioning agent, an emollient, and a humectant, wherein the composition comprises no more than about 2.0 wt% of any paraffin-based components.
  2. 2 A composition according to claim 1, wherein the composition is substantially free of any paraffin-based components.
  3. 3. A composition according to claim 1 or claim 2, wherein the humectant and emollient, which are different materials.
  4. 4 A composition according to any preceding claim, wherein the skin-conditioning agent comprises one or more components selected from octyldodecanol, echium plantagineum seed oil, Helianthus Annuus seed oil unsaponi fiabl es, extract of Cardiospermum Halicacabum, 5-ureidohydantoin, levomenol, biotin, an Aloe vera-containing component, and/or an oat-containing component.
  5. 5 A composition according to any preceding claim, wherein the emollient comprises one or more selected from isostearyl isostearate, caprylic or capric triglyceride, decyl oleate, C12-Cis alkyl benzoate, myristyl myristate, cococapryl ate or coco-caprate, or any natural oil or butter.
  6. 6 A composition according to claim 5, wherein the emollient comprises isostearyl isostearate.
  7. 7 A composition according to any preceding claim, wherein the humectant comprises one or more selected from glycerine, sodium pyrrolidone carbonic acid (sodium PCA), sodium hyaluronate, propanediol, zinc pyrrolidone carbonic acid (zinc PCA), betaine, panthenol, or natural plant extracts.
  8. 8. A composition according to any preceding claim, wherein the composition is completely free of any paraffin-based components.
  9. 9. A composition according to any preceding claim, wherein the composition comprises from about 0.5 to about 10 wt% of the skin-conditioning agent
  10. 10 A composition according to claim 9, wherein the composition comprises from about 2 to about 8 wt% of the skin-conditioning agent
  11. 11 A composition according to any preceding claim, wherein the composition comprises from about 5 to about 20 wit% of the emollient.
  12. 12. A composition according to claim 11, wherein the composition comprises from about 2 to about 25 wt% of the emollient.
  13. 13. A composition according to any preceding claim, wherein the composition comprises from about I to about 10 wt% of the humectant.
  14. 14 A composition according to claim 13, wherein the composition comprises from about 1.5 to about 8 wt% of the humectant.
  15. 15. A composition according to any preceding claim, wherein the composition is in the form of a spray, a cream or a lotion, a balm, a gel, a serum, an oil, or a solid stick.
  16. 16 A composition according to any preceding claim, further comprising one or more additive components selected from a chelating agent, a preservative, a stabiliser or thickener, an emulsion stabiliser or thickener, a non-ionic emulsifier, and a pH adjuster.
  17. 17 A composition according to any preceding claim for use in the treatment of dry skin conditions, such as but not limited to, psoriasis, eczema, and dermatitis.
  18. 18 A method of manufacturing a haemostat composition according to any of claims 1-16, the method comprising the steps of combining a skin-conditioning agent, an emollient, and a humectant, wherein the composition comprises no more than about 2.0 wt% of any paraffin-based components.
  19. 19 A method according to claim 18, wherein the humectant and emollient are combined together before addition of the skin-conditioning agent.
GB1908076.1A 2019-06-06 2019-06-06 Skin treatment composition Withdrawn GB2584647A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB1908076.1A GB2584647A (en) 2019-06-06 2019-06-06 Skin treatment composition
PCT/GB2020/051324 WO2020245569A1 (en) 2019-06-06 2020-06-02 Skin treatment composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1908076.1A GB2584647A (en) 2019-06-06 2019-06-06 Skin treatment composition

Publications (2)

Publication Number Publication Date
GB201908076D0 GB201908076D0 (en) 2019-07-24
GB2584647A true GB2584647A (en) 2020-12-16

Family

ID=67386266

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1908076.1A Withdrawn GB2584647A (en) 2019-06-06 2019-06-06 Skin treatment composition

Country Status (2)

Country Link
GB (1) GB2584647A (en)
WO (1) WO2020245569A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3135894A1 (en) 2022-05-29 2023-12-01 Formule&Sens Cosmetic composition in the form of a compact solid comprising a wax of plant origin, a particular liquid compound, and a solid or semi-solid compound based on triglycerides of plant origin.

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1454622A1 (en) * 2003-03-04 2004-09-08 Johnson & Johnson Consumer Companies, Inc. Skin moisturizing composition
EP1473026A1 (en) * 2003-04-30 2004-11-03 Beiersdorf AG Cosmetic stick containing a self-tanning agent
WO2006000867A1 (en) * 2004-06-22 2006-01-05 Ali Altunkaya Compositions for topical treatment
US20070098647A1 (en) * 2005-09-28 2007-05-03 Neubourg Skin Care Gmbh & Co. Kg Skin care products
WO2009125182A1 (en) * 2008-04-10 2009-10-15 Prime Interaction Holdings Limited A product for topical administration
US20100303742A1 (en) * 2006-09-08 2010-12-02 Norman Turkowitz Skin compositions containing hydrocortisone
EP2494968A1 (en) * 2011-03-01 2012-09-05 Dr. Theiss Naturwaren GmbH Compound, in particular dermatological ointment with Olea Europaea Fruit Oil and Silver
CN108113894A (en) * 2017-12-26 2018-06-05 深圳市芭格美生物科技有限公司 A kind of infant's activity milky lotion and preparation method thereof
CN109745256A (en) * 2017-11-07 2019-05-14 陕西博鸿生物科技集团有限公司 A kind of skin care item for steroid dependent dermatitis nursing

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007031650A1 (en) * 2007-07-06 2009-01-08 Stada Arzneimittel Ag Dermatology for the treatment and / or care of the skin in atopic dermatitis
PT3266443T (en) * 2016-07-08 2019-05-29 Omega Pharma Innovation & Dev Nv Topical moisturizing composition and dispenser containing same

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1454622A1 (en) * 2003-03-04 2004-09-08 Johnson & Johnson Consumer Companies, Inc. Skin moisturizing composition
EP1473026A1 (en) * 2003-04-30 2004-11-03 Beiersdorf AG Cosmetic stick containing a self-tanning agent
WO2006000867A1 (en) * 2004-06-22 2006-01-05 Ali Altunkaya Compositions for topical treatment
US20070098647A1 (en) * 2005-09-28 2007-05-03 Neubourg Skin Care Gmbh & Co. Kg Skin care products
US20100303742A1 (en) * 2006-09-08 2010-12-02 Norman Turkowitz Skin compositions containing hydrocortisone
WO2009125182A1 (en) * 2008-04-10 2009-10-15 Prime Interaction Holdings Limited A product for topical administration
EP2494968A1 (en) * 2011-03-01 2012-09-05 Dr. Theiss Naturwaren GmbH Compound, in particular dermatological ointment with Olea Europaea Fruit Oil and Silver
CN109745256A (en) * 2017-11-07 2019-05-14 陕西博鸿生物科技集团有限公司 A kind of skin care item for steroid dependent dermatitis nursing
CN108113894A (en) * 2017-12-26 2018-06-05 深圳市芭格美生物科技有限公司 A kind of infant's activity milky lotion and preparation method thereof

Also Published As

Publication number Publication date
GB201908076D0 (en) 2019-07-24
WO2020245569A1 (en) 2020-12-10

Similar Documents

Publication Publication Date Title
US9095522B2 (en) High SPF transparent or translucent, cytoprotective, biodegradable, UV radiation resistant compositions
KR100844036B1 (en) Cosmetic preparation
US6589537B2 (en) Infant skin care composition
JPS59108716A (en) Antiacne composition
US6193987B1 (en) Lubricating composition for hands and skin
US9713582B2 (en) Multi-layered cosmetic composition
EP0937453A2 (en) Cosmetic and tissue cleansing and moisturizing composition
JP7194483B2 (en) skin composition booster oil
JP2015510915A (en) Dermal cosmetic composition having sedative effect and use thereof
CA2981405C (en) Moisturizing compositions comprising vegetable butter, vegetable oil, and starch
US20020012697A1 (en) Cosmetic and tissue cleansing and moisturizing composition
US10736836B2 (en) Method of treating external tissues with waxes
JP2016531948A (en) Composition
US7615231B2 (en) Methods for enhancing the morphology, tone, texture and/or appearance of skin or hair using a meadowlactone
US11564963B2 (en) Topical compositions, process of large-scale manufacture, and method of use
EP1074245A2 (en) Composition using mineral salts for therapeutic treatment
WO2014041542A2 (en) Topical compositions for the treatment of acne
US20110086115A1 (en) Vegetal-Derived, Water-Absorbing Composition
EP2134314A1 (en) High spf transparent or translucent, cytoprotective, biodegradable, uv radiation resistant compositions
GB2584647A (en) Skin treatment composition
US20200000721A1 (en) Aqueous compositions and associated cream formulations
RU2663910C1 (en) Cosmetic cream for baby skin protection against wind and weather
EP3383362A1 (en) Skin care composition
JP2004123661A (en) Skin care preparation for external use
JP7398589B1 (en) External pain relief preparation containing ginger ingredients

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)